Journal List > J Korean Soc Radiol > v.73(4) > 1087577

Jung, Jung, Kim, Choi, Kim, Han, Bae, Kwon, and Cha: Intra-Arterial Therapy for Cardioembolic Internal Carotid Artery Terminus Occlusion: The Past and Present Status in Real Practice

Abstract

Purpose

There is little data on the effect of intra-arterial therapy (IAT) in acute cardioembolic internal carotid artery terminus (ICAT) occlusion that has poor prognosis. We determined procedural and clinical outcomes in patients with acute cardioembolic ICAT occlusion treated with different methods of IAT.

Materials and Methods

On retrospective review of our registry, patients with cardioembolic ICAT occlusion were categorized as thrombolytic-based IAT group (TLG) and thrombectomy-based IAT group (TEG) according to the primary endovascular technique. Subsequently, procedural and clinical outcomes were compared.

Results

Fifty-five patients had cardioembolic ICAT occlusion and 18 patients were assigned to TLG and 37 patients to TEG. The rate of complete reperfusion was significantly higher and the groin puncture to reperfusion time was significantly shorter in TEG than those in TLG. There was a trend towards functional outcome at 3 months in the TEG group; however, it was not statistically significant (p = 0.06). Age, baseline Albert Stroke program early CT score and puncture to reperfusion time were factors affecting unfavorable outcome at 3 months, on multivariable analysis.

Conclusion

Thrombectomy-based IAT has advantages over thrombolytic-based IAT in terms of the reduction of groin puncture to reperfusion time and improvement of the rate of complete reperfusion.

INTRODUCTION

Acute ischemic stroke with the occlusion of internal carotid artery terminus (ICAT) is associated with a high rate of mortality and poor functional outcome in survivors (12). Early, complete revascularization of the occluded internal carotid artery (ICA) is essential to improve outcome in this condition (3). However, pharmacological treatment using intravenous (IV) or intra-arterial (IA) thrombolysis is associated with lower recanalization rates in ICAT occlusion, mainly because of large clot burden (1456). Additional to the IA thrombolysis, several methods of mechanical clot disruption using microcatheter, microguidewire balloon or stent are attempted to improve recanalization rates for large vessel occlusions. These methods facilitate pharmacologic thrombolysis by fragmenting the clot and increasing the surface area exposed to lytic agents. Some previous studies showed higher recanalization rates of these multimodal approaches than IA thrombolysis alone, but the clinical benefit is unclear (78910).
Recent advances in IA techniques and thrombectomy devices such as Penumbra System (PS) (Penumbra Inc., Alameda, CA, USA) and stent retrievers (Solitaire FR, ev3, Irvine, CA, USA or Trevo retriever, Concentric Medical Inc., Mountain View, CA, USA) lead to high rate of recanalization and have changed the concept of intra-arterial therapy (IAT) from pharmacological thrombolysis to mechanical thrombectomy (111213).
In our institution, the PS and Solitaire stent have been available since December, 2008 and July, 2010, respectively. These advances provide promising measures toward improving results of endovascular revascularization therapy (ERT). We aimed to compare the results of multimodal ERT approaches based on thrombolytic therapy versus mechanical thrombectomy, in patients with cardioembolic ICAT occlusion.

MATERIALS AND METHODS

Patients

This study was conducted with the approval of our Institutional Review Board, and informed consent from the patients or their legal representatives was waived.
We screened consecutive patients with acute ischemic stroke who underwent ERT at the Seoul National University Bundang Hospital from September 2003 to January 2015. Clinical and radiologic data were reviewed from a total of 614 patients who were treated by ERT for acute ischemic stroke in our medical center. Clinical data included the following: demographic information; time from stroke onset or last normal time to treatment; baseline National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) score at 3 months. Computed tomography (CT) and/or magnetic resonance image (MRI) obtained before ERT were also reviewed. All the patients underwent stroke MR imaging to select eligible patients for ERT within 8 hours, with the exception of those patients who had contraindication of MRI. Multimodal CT scans (non-contrast CT, CT angiography, and perfusion CT) were performed in patients 1) who presented < 3 hours after symptom onset, or 2) with contraindication to MR imaging. Angiograms were reviewed for the location of the occlusion, clot burden, and reperfusion status after ERT.
Patients were excluded from the analysis if they 1) had not angiographically demonstrated complete occlusion of the ICAT (n = 459) that was defined as the ICA occlusion involving the ICA bifurcation area, 2) had non-cardioembolic stroke (n = 76), 3) had symptom onset to hospital arrival of > 8 hours (n = 16), 4) had an NIHSS score < 4 and no prior neurologic event (n = 2) or ≥ 2 premorbid mRS (n = 6) (Fig. 1).

ERT Procedure and the Technical Strategy for ICAT Occlusion

All procedures were performed using femoral artery approach and local anesthesia. A 6-Fr coaxial guiding system (Shuttle SL Flexor; Cook Medical, Bloomington, IN, USA and Envoy 6-Fr, Cordis, Miami Lakes, FL, USA) or a 9-Fr balloon guide catheter (Optimo; Tokai Medical Products, Inc., Japan or Cello; Medtronic, Irvine, CA, USA) was introduced through a femoral sheath into the carotid artery of concern. A heparinized saline solution was continuously perfused through the catheter during the procedure.
Multimodal combination technique generally used for treating patients with ICAT occlusion consist of 1) pharmacological thrombolysis, 2) mechanical disruption using a microguidewire or a balloon catheter, 3) mechanical thrombectomy using a guiding catheter, PS or Solitaire stent, and 4) permanent stenting with a balloon-expandable or self-expandable stents (Neuroform, Boston Scientific, Fremont, CA, USA; Enterprise, Codman Neurovascular, Miami Lakes, FL, USA; Solitaire FR, ev3, Irvine, CA, USA).
The technical strategy of the multi-modal approach of ERT has been changed in our institution due to the introduction of th-rombectomy devices such as PS or Solitaire FR. Before the th-rombectomy device was available, the ICAT occlusion was initially treated by suction thrombectomy using a guiding catheter to decrease the thrombus burden. Residual thrombus was then treated by pharmacological thrombolysis and mechanical disruption. If recanalization was not achieved, permanent stenting was considered for recanalization. After PS and Solitaire stent became available, mechanical thrombectomy using a guiding catheter, PS or Solitaire stent was initially attempted for recanalization on a case-by-case basis. The technique of forced-suction thrombectomy using a reperfusion catheter of PS without a separator was used and described by Kang et al. (14). If mechanical thrombectomy failed, pharmacological thrombolysis, mechanical disruption or permanent stenting were considered. Therefore, we divided patients into the thrombolytic-based IAT group (TLG) and the thrombectomy-based IAT group (TEG) according to the primary method for ERT.
Urokinase was used as the thrombolytic agent with a maximum dose of 800000 U, and Glycoprotein IIb/IIIa receptor antagonist was also used (Reopro 10 mg or tirofiban 10 µg/kg as the maximum dose). Urokinase was manually infused in 20000 U aliquots at 1 or 2-minute intervals between doses and directly into or near the clots.

Imaging Analysis

Two experienced neuroradiologists (B. S. C. and J. H. K.) who had 7 and 22 years, respectively, of clinical experience and who were unaware of the patients' histories or treatments, scored the Albert Stroke Program Early CT Score (ASPECTS) using the diffusion weighted image (DWI) or cerebral blood volume (CBV) map of the perfusion CT (1516).
The ICAT occlusions were categorized as an L or T type lesion, based on functional nature of collateral flow patterns on angiography (17). If the ipsilateral anterior cerebral artery (ACA) territory was filled by collateral flow from contralateral ICA, it was defined as a functional L type occlusion; and if the ipsilateral ACA flow was also compromised, it was defined as a functional T type occlusion.
The angiographic clot burden score (ACBS) was defined according to the clot extent and location determined by cerebral angiography including super-selective angiography with a microcatheter performed during ERT. The ACBS was modified from the previous report in order to determine the clot burden score using CT angiography (18) as follows: 1) ICA was divided as intradural and extradural segments by ophthalmic artery and then given 2 points to its segment. More specifically, 1 point was given, if less than half length of intradural segment was involved or only 1 segment was involved between cavernous, petrosal and cervical segment ICA. 2) M1 was divided as proximal and distal half segment that was given 1 point. 3) M2, A1, and A2 were also given 1 point, respectively, if thrombus was located at each of the arteries regardless of thrombus length and number of involv-ed arteries.

Outcome Evaluations

Clinical outcome measurement at 3 months after stroke onset included mortality and disability, measured according to mRS score. We dichotomized outcome according to the functional de-pendency. Patients with a mRS score ≤ 2 were in the favorable outcome (functionally independent) group and those with a mRS score > 2 were in the unfavorable outcome (functionally dependent) group. The complete reperfusion was defined as modified treatment in cerebral infarction (mTICI) grade 2b or 3 and futile recanalization was defined by the occurrence of unfavorable outcome despite complete reperfusion (19). The reperfusion time was defined as the time interval from the puncture to the final reperfusion with TICI ≥ 2a. Procedure-related complications, such as vascular perforation or arterial dissection, were also assessed. Procedural distal emboli (PDE) into the ipsilateral or contralateral ACA were also evaluated and defined as a new site occlusion distal to A1 segment of ACA.
Symptomatic intracranial hemorrhage was defined as any he-morrhagic transformation seen on the 24-hour CT scan and as-sociated with a decline of ≥ 4 points in the NIHSS score within 24 hours or leading to a patient's death (20). All other hemorrhages were defined as asymptomatic.

Statistical Tests

The baseline characteristics for the TLG versus the TEG were compared using the χ2 test for categorical variables and the Student t-test or the Mann-Whitney U test for continuous variables. Multivariate analyses were performed to identify predictors for unfavorable outcome at 3 months. Receiver operating characteristic curves were constructed to obtain the cutoff DWI or CBV ASPECTS for discriminating between patients with and without functional dependency at 3 months. Significance was set at the 2-tailed p < 0.05 level. We presented the values as frequencies (percentages), means (standard deviations), or medians [interquartile ranges (IQRs)], as appropriate. All statistical analyses were performed using SPSS 17.0.1 (SPSS Inc., Chicago, IL, USA).

RESULTS

Among the screened 614 patients, 55 patients with ICA occlusion met the inclusion and exclusion criteria for this study. Eighteen patients were included in the TLG and the remaining 37 patients were included in the TEG, respectively. The patients' baseline characteristics were summarized in Table 1. There were no statistical differences in baseline characteristics between the groups. Cardioembolic sources of stroke were atrial fibrillation in 50 patients (90.9%), large patent foramen ovale in 2 patients, cardiac arrhythmia except atrial fibrillation that required pacemaker in 1 patient, ischemic heart disease accompanied by inferior wall akinesia in 1 patient, and prosthetic mitral valve in 1 patient.
In the TLG, pharmacological thrombolysis and mechanical disruption were attempted in all cases. Suction thrombectomy with a guiding catheter was performed in 3 cases in order to de-crease the thrombus burden in the ICA; and permanent stenting of the intracranial artery was performed in 3 cases as the final option. In the TEG, reperfusion could be achieved in 12 of 37 cases only by mechanical thrombectomy using PS and/or the Solitaire stent without thrombolytics. Pharmacological thrombolysis and mechanical disruption were also conducted in 9 cases. One case in the thrombectomy group had permanent stenting that was used as a rescue method for procedure-related arterial dissection in the cervical segment of the ICA.
The procedural and clinical outcomes were summarized in Table 2. The median dose of urokinase was significantly lower in TEG than in TLG (median [IQR], 20 [0-100] vs. 300 [87.5-500], × 103 U; p < 0.01). The reperfusion time was also significantly shorter in TEG than in TLG (median [IQR], 38 [18-78] vs. 142 [102-169], min; p < 0.01). The rate of complete reperfusion with mTICI of 2b or 3 was significantly higher in TEG than in TLG (78.4% vs. 44.4%; p = 0.01). The rate of futile recanalization was relatively lower in TEG than in TLG, but without statistical significance (58.6% vs. 87.5%, p = 0.13). The statistical trend showed that TEG had more chance to achieve the favorable clinical outcome with mRS ≤ 2 at 3 months than TLG (Fig. 2, Table 2). Symptomatic intracranial hemorrhage and all-cause mortality at 3 months showed no statistical difference between 2 groups. Although PDE into the ACA did not show statistical difference between the 2 groups, all patients with PDE into the ACA had unfavorable outcome at 3 months. Mild procedural complications occurred in 4 cases of the TLG and in 6 of the TEG.
Forty of 55 patients (72.7%) with mRS score > 2 at 3 months were categorized as the "unfavorable outcome" group in dichotomized analysis. In the multivariate logistic regression analysis taking functional outcome at 3 months as a dependent variable, age [adjusted odds ratio (OR), 1.11 per 1 year increase; 95% confidence interval (CI), 1.02 to 1.21; p = 0.02], baseline ASPECT score (adjusted OR, 0.41 per 1 point increase; 95% CI, 0.22 to 0.77; p < 0.01), and time from groin puncture to reperfusion or completion of procedure (adjusted OR, 1.03 per 1 minute increase; 95% CI, 1.01 to 1.06; p < 0.01) were significantly associated with unfavorable outcome at 3 months (Table 3). This model included only the statistically significant variables from the univariate logistic regression model.
The optimal cutoff DWI or CBV ASPECTS to predict patients with favorable outcome at 3 months was ≥ 5, with a sensitivity of 79%, specificity of 74%, and an area under the curve (AUC) of 0.835 (Fig. 3). On excluding 6 patients without DWI, the optimal cutoff was also ≥ 5, with a sensitivity of 80%, specificity of 72.4%, and an AUC of 0.809. Overall, 19 (67.9%) of 28 patients with baseline ASPECT ≥ 5 and 5 (17.2%) of 29 patients with baseline ASPECT < 5 had mRS scores ≤ 2 at 3 months (p < 0.01) (Fig. 3). There was no significant difference in the rate of symptomatic intracranial hemorrhage between the groups [6 of 29 (20.7%) in patients with ASPECTS < 5 vs. 3 of 26 (11.5%) of patients with ASPECTS ≥ 5, p = 0.36].
Ten of 55 patients (18.2%) were categorized as a functional T type occlusion and all had an unfavorable outcome at 3 months. Of these, 5 patients had mRS 5 at 3 months, and the remaining 5 patients died before 3 months. The DWI or CBV ASPECTS were significantly lower in patients with functional T type occlusion than in patients with L type occlusion, although there was no difference in NIHSS at admission between the groups. In addition, the rate of complete reperfusion was significantly lower in patients with functional T type occlusion than those with the L type occlusion.

DISCUSSION

Our study showed that thrombectomy based multimodal ERT (TE-MERT) for cardioembolic ICAT occlusion has potential advantages over thrombolytic therapy based multimodal ERT (TL-MERT) to improve the clinical outcome. First, TE-MERT can reduce the time from groin puncture to reperfusion as well as the total dose of urokinase. Second, the reperfusion rate with mTICI ≥ 2b in TE-MERT (78.4%) was higher than that in TL-MERT (44.4%).
Recently, new devices such as PS and stent-retrievers showed their superior efficacy on reperfusion rate than Merci retrievers or other IA thrombolytics, especially in anterior circulation (71112131421). The systematic review of IAT for acute ischemic stroke due to ICA occlusion showed higher recanalization rate (69% vs. 48%, p = 0.001) and favorable outcome (34% vs. 12%, p < 0.001) in mechanical thrombectomy group than for IA thrombolysis (21). Our result supported the conclusion of the systematic review, although we included only isolated ICAT occlusions from a suspected cardioembolic source.
The results indicated that baseline ASPECTS, age and time from groin puncture to reperfusion were independent predictors for unfavorable outcome at 3 months after stroke. Recently, it is emphasized that procedure time is a very important factor for reducing the number of futile recanalization, as well as for successful recanalization (22). Rai et al. (23) showed that procedure predictors affecting the favorable outcome included successful recanalization (p < 0.01), collateral support (p = 0.0008), distal occlusion (p = 0.001), and a shorter procedure duration (p = 0.01) (23). Hassan et al. (22) showed that the rates of favorable outcome in cases with a procedure time of ≥ 60 minutes were lower than the rates observed in the placebo group in the Prourokinase for Acute Ischemic Stroke Trial. Moreover, a recently published clinical trial showed the beneficial effect of embolectomy using stent retriever on clinical outcome in patients with proximal artery occlusion in the anterior circulation; this also emphasized that rapid endovascular treatment and early reperfusion improved functional outcomes and reduced mortality (24). In our series, the time from the groin puncture to reperfusion time was significantly reduced in the TEG.
We used the DWI-ASPECTS to assess the lesion volume, due to the MR-based protocol of patient selection for ERT, except for patients with contraindication of MR study. In our series, 29 of 55 patients (52.7%) had baseline DWI or CBV ASPECTS ≤ 4, despite the relative short duration of onset to hospital arrival time (median [IQR], 80 [49-170], minutes). The DWI-ASPECTS tends to be higher than ASPECTS measured by CT, because of the high sensitivity of the DWI to detect early ischemic changes in acute ischemic stroke (15). Furthermore, it could also be facilitated by poor collateral circulation in ICAT occlusion. However, we attempted to treat these patients with low ASPECTS if they had no or only subtle signal changes on fluid-attenuated inversion recovery image because of the high rate of mortality and poor functional outcome in survivors of ICAT occlusion (25). As a result, the baseline ASPECTS ≥ 5 of DWI was predictive for favorable outcomes at 3 months with a sensitivity of 80%, and specificity of 72.4%, respectively. In studies of IV thrombolysis, the cutoff value of DWI ASPECTS was < 5 for a poor clinical outcome and ≥ 7 for good clinical outcome (2627), while the cutoff values of ASPECTS for good and poor clinical outcomes have not been defined in the ERT of cardioembolic ICAT occlusion.
It is notable that the rate of complete reperfusion and favorable outcome at 3 months were significantly lower in patients with functional T type occlusion. Patients with functional T type occlusion had lower baseline ASPECT score than those in patients with L type occlusion, despite the lack of differences in st-roke severity at admission. It showed that the collateral flow patterns at initial presentation could distinguish the nature and im-pact of ICA occlusion on reperfusion and subsequent clinical outcomes in AIS, as demonstrated in the previous study (17).
The clinical significance of PDE has been occasionally overlooked in many studies for ERT (19). Table 4 summarized the case series that describes the incidence of PDE according to the methods and devices used in ERT (282930). Mechanical disruption has the highest incidence of PDE suggesting that the incidence of PDE varies depending on the techniques and devices used. Todo et al. (30) suggested that PDE requires additional procedure time for complete recanalization and is associated with the clinical outcome as well as patient's mortality. In our series, PDE into ACA was more frequent in the TLG, and was associated with mortality and poor functional outcome; this was in agreement with another report analyzing the effect of new embolic ACA occlusion (31). Therefore, any effort to reduce PDE into the ACA would improve clinical outcome, regardless of the techniques or devices used for ERT.
Our study had some limitations due to its retrospective design. First, the number of cases in both groups was too small to achieve statistical significance regarding the clinical outcome. Second, as the devices used to remove the thrombus were heterogeneous, we could not assess the efficacy of a single device. Therefore, further studies are essential to demonstrate which thrombectomy device is more effective and safe for use in recanalization of cardioembolic ICAT occlusion, e.g., the stent retrievers or the PS. Third, we included large proportion of patients with low baseline DWI or CBV ASPECTS, who were not included in the clinical trial. Despite the possible reasons for the high rate of futile recanalization, our study reflected real practice and utilized unbiased sample from target population with acute ICAT occlusion. Fourth, as the TLG was an historical control group, selection bias was inevitable and the devices such as the guiding catheter, microcatheter, and microwire, except for the thrombectomy devices, could not be controlled.
In conclusion, the TE-MERT of cardioembolic ICAT occlusion may have technical advantages over TL-MERT in that the former 1) reduces the time from puncture to reperfusion, and 2) achieves more complete reperfusion. As a result, these technical advantages of the TE-MERT could be expected to achieve a favorable outcome.

Figures and Tables

Fig. 1

Flow sheet showing the study design and patient exclusion criteria. ICA = internal carotid artery, LNT = last normal time, MERT = multimodal endovascular revascularization therapy, mRS = modified Rankin Scale, NIHSS = National Institutes of Health Stroke Scale

jksr-73-230-g001
Fig. 2

Modified Rankin Scale score at 3 months. IAT = intra-arterial therapy, TEG = thrombectomy-based IAT group, TLG = thrombolytic-based IAT group

jksr-73-230-g002
Fig. 3

Receiver operating characteristic curves of scoring of Alberta Stroke Programme Early CT Score (ASPECTS) using diffusion-weighted imaging or cerebral blood volume map on perfusion CT for predicting unfavorable outcome (mRS ≥ 3) at 3 months (A) and distribution of functional dependency at 3 months according to the baseline ASPECTS ≥ 5 or < 5 (B). AUC = area under the curve, mRS = modified Rankin Scale

jksr-73-230-g003
Table 1

Baseline Characteristics

jksr-73-230-i001
Total (n = 55) Technical Strategies of ERT
TLG (n = 18) TEG (n = 37) p
Age, mean (SD), y 68.7 (12.3) 67.7 (13.3) 69.1 (12.0) 0.68
Male, n (%) 22 (40.0) 6 (33.3) 16 (43.2) 0.48
Medical history, n (%)
 Atrial fibrillation 50 (90.9) 15 (83.3) 35 (94.6) 0.17
 Hypertension 30 (54.5) 8 (44.4) 22 (59.5) 0.29
 Diabetes mellitus 13 (23.6) 3 (16.7) 10 (27.0) 0.40
 Hyperlipidemia 6 (10.9) 1 (5.6) 5 (13.5) 0.37
 Coronary artery disease 8 (14.5) 3 (16.7) 5 (13.5) 0.76
 Current or previous smoker 7 (12.7) 1 (5.6) 6 (16.2) 0.27
 Previous stroke 6 (10.9) 0 6 (16.2) 0.07
Location of stroke in left hemisphere, n (%) 24 (43.6) 8 (44.4) 16 (43.2) 0.93
Functional type of occlusion, n (%) 0.34
 T type occlusion 10 (18.2) 3 (12.5) 7 (22.6)
 L type occlusion 45 (81.8) 21 (87.5) 24 (77.4)
Baseline NIHSS, median [IQR] 17 [13-20] 16.5 [15-20.75] 17 [12.5-20] 0.22
Baseline ASPECTS score, median [IQR] 4 [2-7] 4.5 [1.5-6] 4 [2-7] 0.43
ACBS, median [IQR] 5 [4-6] 4 [3-6] 5 [4-6] 0.15
Time from stroke onset or LNT to hospital arrival, median [IQR], min 80 [49-170] 71 [30-188.75] 80 [57.5-153] 0.64
Time from stroke onset or LNT to groin puncture, median [IQR], min 198 [165-280] 204.5 [163.75-274] 195 [163-294.5] 0.97
Intravenous tPA, n (%) 40 (72.7) 11 (61.1) 29 (78.4) 0.18

ACBS = Angiographic Clot Burden Score, ASPECTS = Albert Stroke Program Early CT Score, ERT = endovascular revascularization therapy, IAT = intra-arterial therapy, IQR = interquartile range, LNT = last normal time, NIHSS = National Institutes of Health Stroke Scale, TEG = thrombectomy-based IAT group, TLG = thrombolytic-based IAT group, tPA = tissue Plasminogen Activator

Table 2

Results of Endovascular Reperfusion Therapy

jksr-73-230-i002
Technical Strategies of ERT
TLG (n = 18) TEG (n = 37) p
Urokinase, median [IQR] × 103, U 300 [87.5-500] 20 [0-100] < 0.01*
Time from groin puncture to reperfusion, median [IQR], min 142 [102-169] 38 [18-78] < 0.01*
Time from stroke onset or LNT to reperfusion, median [IQR], min 334 [292-384] 245 [194-359.5] 0.06
Reperfusion rate (TICI ≥ 2b), n (%) 8 (44.4) 29 (78.4) 0.01*
Futile recanalization, n (%) 7 (87.5) 17 (58.6) 0.13
PDE into ACA, n (%) 5 (27.8) 5 (13.5) 0.20
Hemorrhagic transformation 11 (61.1) 16 (43.2) 0.21
Symptomatic ICH, n (%) 4 (22.2) 5 (13.5) 0.41
Procedural complications, n (%) 4 (22.2) 6 (16.2) 0.59
Favorable outcome (mRS ≤ 2) at 90 days, n (%) 2 (11.1) 13 (35.1) 0.06
Mortality at 90 days, n (%) 3 (16.7) 8 (21.6) 0.67

*Statistically significant.

Reperfusion was defined as the first visualization of reflow in the internal carotid artery and middle cerebral artery.

ACA = anterior cerebral artery, ERT = endovascular revascularization therapy, IAT = intra-arterial therapy, ICH = intracranial hemorrhage, IQR = interquartile range, mRS = modified Rankin Scale, LNT = last normal time, PDE = procedural distal emboli, TEG = thrombectomy-based IAT group, TICI = treatment in cerebral infarction, TLG = thrombolytic-based IAT group

Table 3

Factors Affecting Unfavorable Outcome at 3 Months after Stroke Onset (The Result of Multiple Logistic Regression Analysis)

jksr-73-230-i003
Adjusted OR* (95% CI) p Value
Age, per 1 year increase 1.11 (1.02-1.21) 0.02
Baseline ASPECT score, per 1 point increase 0.41 (0.22-0.77) < 0.01
Time from groin puncture to reperfusion or completion of procedure, per 1 minute increase 1.03 (1.01-1.06) < 0.01

*Adjusted for age, technical strategies of ERT, baseline NIHSS, baseline ASPECT score, time from puncture to recanalization, reperfusion rate (TICI ≥ 2b) and hemorrhagic transformation.

ASPECT = Albert Stroke program early CT, CI = confidence interval, ERT = endovascular revascularization therapy, NIHSS = National Institutes of Health Stroke Scale, OR = odds ratio, TICI = treatment in cerebral infarction

Table 4

The Incidence of Procedural Distal Emboli Using the Different Techniques and Devices

jksr-73-230-i004
Studies Tools Occlusion Site Emboli to Index Territory Emboli to Other Territory Add-On Procedure Comment
Kim et al. (29) (n = 19) IV t-PA
IA UK
Wire
MCA (M1 or M2) 18 (94.7%) 0% None M3 (8), M4 (10)
Progressed lysis in 21%
Todo et al. (30) (n = 20) IV t-PA
IA t-PA
PS
ICA, MCA, BA 6 (30%) NA Yes Additional time due to PDE; 45.8 minutes
Machi et al. (28) (n = 56) IV t-PA
IA t-PA
Solitaire
ICA, MCA, BA NA 3.4% (2) NA BAO (PICA), ICAT occlusion (ACA)

ACA = anterior cerebral artery, BA = basilar artery, BAO = basilar artery occlusion, IA UK = intra-arterial urokinase, ICA = internal carotid artery, ICAT = internal carotid artery terminus, IV t-PA = intravenous tissue plasminogen activator, MCA = middle cerebral artery, PDE = procedural distal emboli, PICA = posterior inferior cerebellar artery, PS = penumbra system

Acknowledgments

The authors thank Bonnie Hami, M.A. (USA) for correcting the English in this article.

References

1. Jansen O, von Kummer R, Forsting M, Hacke W, Sartor K. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR Am J Neuroradiol. 1995; 16:1977–1986.
2. Hernández-Pérez M, Pérez de la Ossa N, Aleu A, Millán M, Gomis M, Dorado L, et al. Natural history of acute stroke due to occlusion of the middle cerebral artery and intracranial internal carotid artery. J Neuroimaging. 2014; 24:354–358.
3. Fischer U, Mono ML, Schroth G, Jung S, Mordasini P, El-Koussy M, et al. Endovascular therapy in 201 patients with acute symptomatic occlusion of the internal carotid artery. Eur J Neurol. 2013; 20:1017–1024.
4. Arnold M, Nedeltchev K, Mattle HP, Loher TJ, Stepper F, Schroth G, et al. Intra-arterial thrombolysis in 24 consecutive patients with internal carotid artery T occlusions. J Neurol Neurosurg Psychiatry. 2003; 74:739–742.
5. Jahan R, Duckwiler GR, Kidwell CS, Sayre JW, Gobin YP, Villablanca JP, et al. Intraarterial thrombolysis for treatment of acute stroke: experience in 26 patients with long-term follow-up. AJNR Am J Neuroradiol. 1999; 20:1291–1299.
6. Zaidat OO, Suarez JI, Santillan C, Sunshine JL, Tarr RW, Paras VH, et al. Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke. 2002; 33:1821–1826.
7. Lin R, Vora N, Zaidi S, Aleu A, Jankowitz B, Thomas A, et al. Mechanical approaches combined with intra-arterial pharmacological therapy are associated with higher recanalization rates than either intervention alone in revascularization of acute carotid terminus occlusion. Stroke. 2009; 40:2092–2097.
8. Qureshi AI, Janjua N, Kirmani JF, Harris-Lane P, Suri MF, Zhou J, et al. Mechanical disruption of thrombus following intravenous tissue plasminogen activator for ischemic st-roke. J Neuroimaging. 2007; 17:124–130.
9. Sorimachi T, Fujii Y, Tsuchiya N, Nashimoto T, Harada A, Ito Y, et al. Recanalization by mechanical embolus disruption during intra-arterial thrombolysis in the carotid territory. AJNR Am J Neuroradiol. 2004; 25:1391–1402.
10. Mokin M, Kass-Hout T, Kass-Hout O, Dumont TM, Kan P, Snyder KV, et al. Intravenous thrombolysis and endovascular therapy for acute ischemic stroke with internal carotid artery occlusion: a systematic review of clinical outcomes. Stroke. 2012; 43:2362–2368.
11. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012; 380:1241–1249.
12. Taschner CA, Treier M, Schumacher M, Berlis A, Weber J, Niesen W. Mechanical thrombectomy with the Penumbra recanalization device in acute ischemic stroke. J Neuroradiol. 2011; 38:47–52.
13. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012; 380:1231–1240.
14. Kang DH, Hwang YH, Kim YS, Park J, Kwon O, Jung C. Direct thrombus retrieval using the reperfusion catheter of the penumbra system: forced-suction thrombectomy in acute ischemic stroke. AJNR Am J Neuroradiol. 2011; 32:283–287.
15. Menon BK, Puetz V, Kochar P, Demchuk AM. ASPECTS and other neuroimaging scores in the triage and prediction of outcome in acute stroke patients. Neuroimaging Clin N Am. 2011; 21:407–423. xii
16. Kim JT, Park MS, Choi KH, Nam TS, Choi SM, Lee SH, et al. The CBV-ASPECT Score as a predictor of fatal stroke in a hyperacute state. Eur Neurol. 2010; 63:357–363.
17. Liebeskind DS, Flint AC, Budzik RF, Xiang B, Smith WS, Duckwiler GR, et al. Carotid I's, L's and T's: collaterals shape the outcome of intracranial carotid occlusion in acute ischemic stroke. J Neurointerv Surg. 2015; 7:402–407.
18. Puetz V, Dzialowski I, Hill MD, Subramaniam S, Sylaja PN, Krol A, et al. Intracranial thrombus extent predicts clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score. Int J Stroke. 2008; 3:230–236.
19. Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013; 44:2650–2663.
20. Higashida R, Furlan A, Roberts H, Tomsick T, Connors B, Barr J, et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol. 2003; 14(9 Pt 2):S493–S494.
21. Kappelhof M, Marquering HA, Berkhemer OA, Majoie CB. Intra-arterial treatment of patients with acute ischemic stroke and internal carotid artery occlusion: a literature review. J Neurointerv Surg. 2015; 7:8–15.
22. Hassan AE, Chaudhry SA, Miley JT, Khatri R, Hassan SA, Suri MF, et al. Microcatheter to recanalization (procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: when do we stop? AJNR Am J Neuroradiol. 2013; 34:354–359.
23. Rai AT, Jhadhav Y, Domico J, Hobbs GR. Procedural predictors of outcome in patients undergoing endovascular therapy for acute ischemic stroke. Cardiovasc Intervent Radiol. 2012; 35:1332–1339.
24. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015; 372:1019–1030.
25. Ziegler A, Ebinger M, Fiebach JB, Audebert HJ, Leistner S. Judgment of FLAIR signal change in DWI-FLAIR mismatch determination is a challenge to clinicians. J Neurol. 2012; 259:971–973.
26. Weir NU, Pexman JH, Hill MD, Buchan AM. CASES investigators. How well does ASPECTS predict the outcome of acute stroke treated with IV tPA? Neurology. 2006; 67:516–518.
27. Nezu T, Koga M, Kimura K, Shiokawa Y, Nakagawara J, Furui E, et al. Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA: SAMURAI rt-PA Registry. Neurology. 2010; 75:555–561.
28. Machi P, Costalat V, Lobotesis K, Maldonado IL, Vendrell JF, Riquelme C, et al. Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg. 2012; 4:62–66.
29. Kim DJ, Kim DI, Byun JS, Jung JY, Suh SH, Kim EY, et al. Simple microwire and microcatheter mechanical thrombolysis with adjuvant intraarterial urokinase for treatment of hyperacute ischemic stroke patients. Acta Radiol. 2008; 49:351–357.
30. Todo A, Minaeian A, Sahni R, Chao KH. Incidence and outcome of procedural distal emboli using the Penumbra thrombectomy for acute stroke. J Neurointerv Surg. 2013; 5:135–138.
31. King S, Khatri P, Carrozella J, Spilker J, Broderick J, Hill M, et al. Anterior cerebral artery emboli in combined intravenous and intra-arterial rtPA treatment of acute ischemic stroke in the IMS I and II trials. AJNR Am J Neuroradiol. 2007; 28:1890–1894.
TOOLS
Similar articles